Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 542541, 8 pages
http://dx.doi.org/10.1155/2014/542541
Research Article

Genetic Testing in Hereditary Breast and Ovarian Cancer Using Massive Parallel Sequencing

1Laboratorio de Genética, UDIAT-Centre Diagnòstic, Corporació Sanitària Parc Taulí Institut Universitari (UAB), Parc Taulí s/n, Sabadell, 08208 Barcelona, Spain
2Unidad de Consejo Genético, Institut Oncològic del Vallès, Corporació Sanitària Parc Taulí, Parc Taulí s/n, Sabadell, 08208 Barcelona, Spain
3Departamento de Investigación Oncológica, Corporació Sanitària Parc Taulí Institut Universitari (UAB), Parc Taulí s/n, Sabadell, 08208 Barcelona, Spain
4Departamento de Oncología Médica, Corporació Sanitària Parc Taulí Institut Universitari (UAB), Parc Taulí s/n, Sabadell, 08208 Barcelona, Spain

Received 27 February 2014; Accepted 5 June 2014; Published 26 June 2014

Academic Editor: Ozgur Cogulu

Copyright © 2014 Anna Ruiz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Miki, J. Swensen, D. Shattuck-Eidens et al., “A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1,” Science, vol. 266, no. 5182, pp. 66–71, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Wooster, G. Bignell, J. Lancaster et al., “Identification of the breast cancer susceptibility gene BRCA2,” Nature, vol. 378, no. 6559, pp. 789–792, 1995. View at Google Scholar · View at Scopus
  3. A. Antoniou, P. D. P. Pharoah, S. Narod et al., “Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies,” The American Journal of Human Genetics, vol. 72, no. 5, pp. 1117–1130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. King, J. H. Marks, and J. B. Mandell, “Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2,” Science, vol. 302, no. 5645, pp. 643–646, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Pruthi, B. S. Gostout, and N. M. Lindor, “Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian cancer,” Mayo Clinic Proceedings, vol. 85, no. 12, pp. 1111–1120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Paradiso and S. Formenti, “Hereditary breast cancer: clinical features and risk reduction strategies,” Annals of Oncology, vol. 22, supplement 1, no. 1, pp. i31–i36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Gerhardus, H. Schleberger, B. Schlegelberger, and D. Gadzicki, “Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review,” European Journal of Human Genetics, vol. 15, no. 6, pp. 619–627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. V. Voelkerding, S. A. Dames, and J. D. Durtschi, “Next-generation sequencing: from basic research to diagnostics,” Clinical Chemistry, vol. 55, no. 4, pp. 641–658, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. R. Bentley, “Whole-genome re-sequencing,” Current Opinion in Genetics and Development, vol. 16, no. 6, pp. 545–552, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Mamanova, A. J. Coffey, C. E. Scott et al., “Target-enrichment strategies for next-generation sequencing,” Nature Methods, vol. 7, no. 2, pp. 111–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. X. S. Puente, M. Pinyol, V. Quesada et al., “Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia,” Nature, vol. 475, no. 7354, pp. 101–105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Choi, U. I. Scholl, W. Ji et al., “Genetic diagnosis by whole exome capture and massively parallel DNA sequencing,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 45, pp. 19096–19101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. Morgan, I. M. Carr, E. Sheridan et al., “Genetic diagnosis of familial breast cancer using clonal sequencing,” Human Mutation, vol. 31, no. 4, pp. 484–491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Walsh, S. Casadei, M. K. Lee et al., “Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 44, pp. 18032–18037, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. de Leeneer, J. Hellemans, J. de Schrijver et al., “Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations,” Human Mutation, vol. 32, no. 3, pp. 335–344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Michils, S. Hollants, L. Dehaspe et al., “Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing,” Journal of Molecular Diagnostics, vol. 14, no. 6, pp. 623–630, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Hernan, E. Borràs, M. de Sousa Dias et al., “Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing,” Journal of Molecular Diagnostics, vol. 14, no. 3, pp. 286–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Feliubadaló, A. Lopez-Doriga, E. Castellsagué et al., “Next-generation sequencing meets genetic diagnostics: Development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes,” European Journal of Human Genetics, vol. 21, no. 8, pp. 864–870, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. V. Tavtigian, M. S. Greenblatt, D. E. Goldgar, and P. Boffetta, “Assessing pathogenicity: overview of results from the IARC unclassified genetic variants working group,” Human Mutation, vol. 29, no. 11, pp. 1261–1264, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. de Leeneer, J. de Schrijver, L. Clement et al., “Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnostics,” PLoS ONE, vol. 6, no. 9, Article ID e25531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. M. Huse, J. A. Huber, H. G. Morrison, M. L. Sogin, and D. M. Welch, “Accuracy and quality of massively parallel DNA pyrosequencing,” Genome Biology, vol. 8, no. 7, article R143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Diez, S. Gutiérrez-Enríquez, and J. Balmaña, “Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing,” Familial Cancer, vol. 9, no. 2, pp. 187–191, 2010. View at Publisher · View at Google Scholar
  23. M. Carvalho, M. A. Pino, R. Karchin et al., “Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1,” Mutation Research, vol. 660, no. 1-2, pp. 1–11, 2009. View at Publisher · View at Google Scholar · View at Scopus